Center for Autism and Related Disorders

From WikiMD's Wellness Encyclopedia

Center for Autism and Related Disorders (CARD) is a prominent organization dedicated to providing services to individuals with autism spectrum disorder (ASD) and related conditions. Founded in 1990 by Dr. Doreen Granpeesheh, CARD has grown to become one of the largest and most comprehensive autism treatment organizations in the world. The organization's mission is to provide the highest quality evidence-based therapy and services to individuals with ASD, aiming to help them achieve their fullest potential.

History[edit | edit source]

The Center for Autism and Related Disorders was established in response to the growing need for effective treatments for ASD. Since its inception, CARD has been at the forefront of research, therapy, and advocacy for autism, contributing significantly to the field's understanding and treatment methodologies. The organization has expanded its reach globally, operating numerous treatment centers across the United States and internationally.

Services[edit | edit source]

CARD offers a wide range of services tailored to meet the individual needs of people with ASD. These services include but are not limited to:

  • Applied Behavior Analysis (ABA) Therapy: A cornerstone of CARD's therapy programs, ABA is an evidence-based treatment known for its effectiveness in improving social, communication, and learning skills in individuals with autism.
  • Early Intervention Services: Recognizing the importance of early diagnosis and treatment, CARD provides specialized services for infants and toddlers to maximize their developmental potential.
  • School-Based Services: CARD collaborates with schools to support students with ASD, offering training for educators, individualized education plan (IEP) assistance, and direct services to students.
  • Adult Services: Understanding that autism is a lifelong condition, CARD offers services designed to support adults with ASD in achieving independence, employment, and social integration.

Research and Advocacy[edit | edit source]

CARD is actively involved in research aimed at advancing the understanding of autism and improving treatment outcomes. The organization collaborates with academic institutions and other research entities to study various aspects of ASD and related disorders. Additionally, CARD advocates for policies and practices that promote the rights and well-being of individuals with autism, working to raise awareness and improve access to services.

Locations[edit | edit source]

With its headquarters in Los Angeles, California, CARD operates numerous treatment centers across the United States. Each center is staffed by trained professionals who specialize in autism therapy and services. CARD's international presence includes centers and partnerships in various countries, reflecting its commitment to addressing the global challenge of autism.

Controversies and Criticisms[edit | edit source]

Like many organizations in the field of autism treatment, CARD has faced criticism and controversy, particularly regarding the intensity and nature of ABA therapy. Critics argue that ABA can be overly rigid and may not respect the autonomy and individuality of people with autism. CARD maintains that its programs are designed with the utmost care and respect for each individual, emphasizing personalized treatment plans that consider the unique needs and preferences of each person.

Conclusion[edit | edit source]

The Center for Autism and Related Disorders continues to play a vital role in the field of autism treatment and advocacy. Through its comprehensive services, research initiatives, and commitment to quality care, CARD strives to improve the lives of individuals with ASD and their families. As the understanding of autism evolves, CARD remains dedicated to adapting its approaches and methodologies to best serve the autism community.


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD